RDR is an independent clinical research site network, 100% dedicated to conducting clinical research, accelerating the development of safe and effective treatments for rare diseases, and providing access to innovative investigational therapies to patients with rare diseases. RDR’s team of expert physicians, researchers, and clinical staff works directly with rare disease foundations, parent networks, and leading academic researchers specializing in rare conditions. RDR’s clinical research sites offer technology-enabled clinical research solutions tailored for rare disease clinical trials, including an accelerated study start-up process, overnight facilities, IP pharmacy and research home health services for decentralized trials.